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Abstract 
A prospective study aimed at  determining the relationship between hepatitis C virus (HCV) infection and 
serum ferritin in Nigerian patients with primary liver cell carcinoma (PLCC) was carried out at the 
University College Hospital (UCH), Ibadan; Nigeria. The  study involved 42 adult Nigerians made up of 
14 healthy subjects as  controls and 14 patients each with PLCC and liver cirrhosis (LC) who consented to 
participate in the study. The subjects were controlled for age and sex. The diagnosis of the diseases was 
made from relevant clinical features, ultrasonography and histology of liver biopsy specimen. Blood 
specimen collected from the subjects were analysed for ferritin by radio-immuno assay using Amersham 
Kits, hepatitis B virus (HBV) infection using HBsAg detection and anti-HCV by ELISA (Sanofi Pasteur. 
France). The study protocol was approved by the Joint UIIUCH Ethical Review Board. Data &shed  
was analysed with the SSPS software at a level of significance of p<O.OS. Serum ferritin >700ng/ml was 
detected only in 50% and 14% of the patients with PLCC and LC respectively with specificity of 93% as 
well as negative (78%) and positive (79%) predictive values. Serum anti-HCV and HBsAg were present 
in 14% and 71% of patients with PLCC respectively (p<0.005). Similarly, 29% and 14% of the patients 
and the Controls respectively were sero-positive for anti HCV while serum HBsAg was detected in equal 
proportions of the patients with LC (50%) and the Controls (43%). There was correlation between 
elevated serum ferritin and HBsAg (x' with Yates correction = 5.04, p= 0.025) but none with serum 
anti-HCV. 
In conclusion, the study shows that serum ferritin level 2 700ng/ml is indicative of PLCC among 
Nigerians especially in the presence of HBV infection but may not be useful when there is associated HCV 
infection. 
Introduction 
Hepatitis C virus (HCV) infection occurs 
globally(1). It presents more with asymptomatic 
course resulting in chronic hepatitis and later 
progressing to primary liver cell carcinma 
(PLCC). Although, W C C  has been associated 
- . x e  with hepatitis B virus izfection in Sigmiq2i. 
v a y  assume increasing trends once 
'x-. -painst HBV becomes efficient as in 
3p.: -- . - - .- - ?sf3,4). Hence, HCV infection 
,,-.- y .re - - - r- 1: ~ e ~ u e l l a e  r mains a burden 
Sime +ere - 5  r r zs r<>  - : xs ine  against the virus. 
Effarts d i m &  z r e - :  c.? PLCC have been 
met with poor success because of the late 
presentation of the patients at hospitals(5). Early 
diagnosis of the disease is therefore necessary. To  
ensure this, various tumour markers have been 
shown to be useful in the diagnosis of PLCC 
among different populations(6,7). Specificaily, 
serum ferritin has been documented to be a useful 
marker in diagnosis of PLCC among Nigcrians(8). 
The significance of serum ferritin in the presence 
of HCV infection remains unknown. This study 
was designed to detennine the level of serum 
ferritin in Nigerian patients with primary liver cell 
carcinuma (PLCC) especially vhcn thcte is 
assuciatcd hepatitis C virus infectim. 
Mateflrrls and Methods 
Fatty-two adult Nigerian subjects wete recruited 
into the study sfiet obitnining infovmed consent. 
the  subjects cumptised 14 apparentl y healthy 
adults as cutitfol (gruup I )  and 14 patients each 
with liver cirrhosis-LC (group 11) and PLCC 
(group 1111. They wete sex and age matched. There 
was no ingestion of multivitamin medication. 
obvious bluud loss at bloud transfusion in any of 
the subject within 12 months prior theit inclusion 
in the study. lh additicm, no subject was anaemic at 
entry Iht0 the study. #efevant clinical features. 
ultrasonogtaphy and histology of liver biopsy 
specimen wete utilised to make the diagncs~s of 
both LC and PLCC. Blood speclmenr - r e  
collected from the subjects fm wted cei' *.I.'LY 
(PCV) estimation. _~ero-anal?~*s iJ 'F--. '.-F 
function tests as met1 .s t'-e &- CC a d  
HCV i n f d . ~  k z e a ?  cC WLF- C t x n t l n  was 
carried m 5 &+--Fw assay using 
Arn~sha- KC! iF-1- 914 K I ~  IM 1051). The 
_cem HI3c?\c (HBk- rnfectrcm) and anti-HCV wcrc 
c!efe--vc! h ELIS.4. Liver functim tests Werc 
m w e d  1- a l l  patients by toutine laboratory 
w w  
The ad! mas carrrcd out affcr obraining clcarancc 
f r m  Imrrt LI C'CH Ethical Review Board. The 
SPSS W ~ d r c a l  package was utilized for data 
entties and analysis ah a micto-computer. The 
Ktuskal Wallis statistics, a hon patamctric 
equivaleni uf the analysis of variancc tcchniquc and 
the Meon Whitncy II tcst, a n m  parametric 
equivalent o f  the student's 1-test wcrc used to 
compare the means uf values crf cmtinuaus 
variables. The Chi-square tcst and Fisher's exact 
tcst Were uscd to detcrmine the statistical 
slgnifir. rlce of the association between two 
catcpurical variables. Thc validity of the diagnostic 
value af fertitrn faf PLCC was alsu examrned by 
calculatrng the ensitrvity, specificity, pusrtrve and 
negatrve ptedrctive values whets the histalugical 
flhdrngs wete the gold standvd. All statistical 
analysts were catrred out at 5% probability level. 
Results 
The farty-two 42 subjects studred wefe made up of 
conttols (14) and patients with PtCC (14) and U: 
(14) They were 4% + 14, 49 +14,and 9 4 3  12 
yem of  age respectrvely. Each guup had 
male female rairo of 11:3. The Chrld Pugh stages of 
the pat~ents In both PLCC and LC were simrlat (4 
and 10 patrents In each group were scored A and B 
respectrrely) The PCV rn the subjects wete 
A?L4c, - ?P:OC; sd 3FL'@/s - for the control subjects 
FK! tk c a r e !  wrc-5 PLCC and LC respectively. 
"-Y KT' tk c m o l  subjects was 
rrr\r-f"'? h-@e thaq tk balw far erther the 
m s  wrlb PLCC (P<OOS) ot LC ( ~ 0 . 0 1 ) .  
Serum femtrn >IWng/ml was detected in 40% uf 
the patrehts wrth PLCC (specificity, negative errid 
posrtrve ptedrctrve values were 93%, 78%, and 
79% tespectrvely, Table 1) cornpiwed to m l y  14% 
of the patrents with U: and nme uf the Cunttals 
who had values serum fertitin abuve the cut-uff 
level. ~ 0 . 0 5  each. Serum antf HCV and HElsAg 
were prcscnt rn 14% and 71% of patrents wrth 
PLCC tcspectrvely (f~0.605, table II) Sl~mrlafly~ 
scrum antr-HCV was present rn 29% and 14% uf 
the patrents wrth LC and cmttols tespectrvelp. 
whrlc scrum HElsAg was detected rn equal 
propattrans uf the mtlents with LC (30%) and the 
Cutitruls (43%]. Elevated sdtum fettrrrn smelated 
with serum H0sAg (X2 wrth Yaws ~ u t r e ~ t l m  = 
4.04, p= 0 024) btrt noi wrih serum rmtr=HClh/ 
Among all the subjects studred, 2 patients each 
wrth PLCC and W had sa=infectron of HDV ard 
HCV wrth the farmsf patients alw havrng e b d  
sctum feltrtrn levels. 
. 
Table 1. The validity of serum ferritin in diagnosing PLCC among adult Nigerian patients at different 
cut-off points. 
Validity(%) 
Ferritin (ug/L) positive negative Sen. Spec. PPV NPV 
< 800 8 26 
% - percentage Sen. - Sensitivip Spec. - Specificity 
PPV - Positive Predictive Value SP\' - Negative Predictive Value 
PLCC - Primary Liver Cell carcinoma 
Table I1 The association between serum ferritin. HBV and HCV in adult Nigerian patients with PLCC, 
LC and contrcls 
Serum ferritin ~700ugIL 
PHCC LC Control 
Number of subjects Total (42) 14 14 14 
@ X' with Yates correction = 5.04, p4.025 for Ferritin & 
HBsAg in PLCC *P=0.64 for ferritin & HCV in PLCC 
PLCC - Primary liver cell carcinoma, LC - Liver Cirrhosis 
HBV - Hepatitis B Virus HCV - Hepatitis C Virus 
HbsAg - Hepatitis B surface Antigen 
. 
Discussion 
Elevated serum ferritin level has been reported to 
be diagnostic of PLCC in different populations 
including Nigerians(6,8). This study has taken into 
consideration the role of blood loss, infectious 
anemia as well as ingestion of iron tablets on serum 
ferritin level hence the packed cell volume of the 
subjects studied are not unexpected. The serum 
ferritin level of >700uglL as diagnostic level for 
PLCC is a better discriminatory level for the 
tumour from liver cirrhosis than the value of 
400uglL earlier reported among Nigerian(8). High 
serum ferrittin levels in our patients with PLCC 
might be due to the production of femtin by the 
tumour rather than to liver necrosis(9). Although, at 
serum ferritin level of >700uglL, two of our 
patients with LC were shown to have elevated 
levels of serum ferritin which may be suggestive of 
occult PLCC. This shows the limitation of 
histological diagnosis in absence of screening with  
a tumour marker. It is b m u  canparabk ro the 
report among Europeans ( lo). 
In view of the vary popcations of arr paitms with 
PLCC having HBV and HCV infeaions. bdh 
viruses could have contributed to the a e t i d m  of 
the disease. Despite the use of ELlSA for assay of 
HBsAg in our study, the correlation o b m d  
between elevated level of serum ferritin 
corroborates previous reports where heamaglution 
method had been utilized for the detection of serum 
HBsAg(8). This also shows that serum level of 
ferritin 2 700nglml is diagnostic of PLCC 
especially in the presence of HBV infection. It 
suggcsts that serum level of ferillin in patients with 
PLCC may be influenced by HBV infection since 
the virus gets intercalated with the hepatocellular 
DNA in aetio-pathogenesis of the tumour. In view 
of the diverse aetiological factors for PLCC, there 
is the need to define the effects of the other causal 
factors like HCV on the expression of the markers 
that may aid diagnosis of the tumour(1 I). In spite 
of the worldwide prevalence of HCV infection and 
its relationship to PLCC, the association between 
serum ferritin and HCV infection has hitherto 
remained unknown among Nigerians. However, 
our study has shown that there is absence of 
correlation between elevated serum levels of 
ferritin and HCV infection in Nigerian patients 
with PLCC. This observation might not be 
unconnected with the predominantly chronic 
clinical course and pathology of HCV 
infection(l2). The presence of elevated level of 
serum ferritin among the two patients who had 
combined infection of HBV and HCV could be due 
to the effects of HBV. However, further study 
involving a larger sample size will be necessary to 
elucidate this observation. 
In conclusion, this study shows that serum ferritin 
level 2 700n&nl is diagnostic of PLCC among 
Si,p-ians. In addition. serurn femtin may not be 
useful m m i n g  for PLCC among Nigerians 
aith H C  infection but the converse holds for 
hose ~nfected with HBV. 
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